Patent Assignment
Reel/Frame 052985/0056
Security Interest
Recorded: 2020-06-12
Pages: 118
Assignor
ADC THERAPEUTICS SA
Executed: 2020-05-19
Assignee
DEERFIELD PARTNERS, L.P.
780 THIRD AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Property
(1)
Dosage Regimes for the Administration of an Anti-CD19 Adc
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 26, 2020
From: UNGAR, DAVID RODNEY; FEINGOLD, JAY MARSHALL
To: ADC THERAPEUTICS AMERICA, INC.
Reel/Frame 051941/0345 →
Assignment of Assignor's Interest
Feb 28, 2020
From: ADC THERAPEUTICS AMERICA, INC.
To: ADC THERAPEUTICS SA
Reel/Frame 051967/0100 →
Assignment of Assignor's Interest
Mar 26, 2020
From: ADC THERAPEUTICS SA
To: MEDIMMUNE LIMITED
Reel/Frame 052238/0244 →
Security Interest
May 19, 2020
From: ADC THERAPEUTICS SA
To: DEERFIELD PARTNERS, L.P., AS GRANTEE
Reel/Frame 052696/0247 →
Termination and Release of Patent Security Agreement
Aug 16, 2022
From: DEERFIELD PARTNERS, L.P.
To: ADC THERAPEUTICS SA
Reel/Frame 061200/0750 →
Patent Security Agreement
Dec 27, 2022
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 062228/0763 →